추가 설명:
Hubei Lingsheng Pharmaceuticals, established in 2010, manufactures and trades cephalosporin APIs, pharmaceutical intermediates, and chiral intermediates, offering contract manufacturing services to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa. The company competes on an experienced R&D staff, delivery speed, production capacity, and flexibility with buyers' specifications and small orders.
평가 & 댓글 남기기